Literature DB >> 29709465

Huntington's disease pattern of transcriptional dysregulation in the absence of mutant huntingtin is produced by knockout of neuronal GLT-1.

Robert B Laprairie1, Geraldine T Petr2, Yan Sun2, Kathryn D Fischer2, Eileen M Denovan-Wright1, Paul A Rosenberg3.   

Abstract

GLT-1 is the major glutamate transporter in the brain, and is expressed in astrocytes and in axon terminals in the hippocampus, cortex, and striatum. Neuronal GLT-1 accounts for only 5-10% of total brain GLT-1 protein, and its function is uncertain. In HD, synaptic dysfunction of the corticostriate synapse is well-established. Transcriptional dysregulation is a key feature of HD. We hypothesized that deletion of neuronal GLT-1, because it is expressed in axon terminals in the striatum, might produce a synaptopathy similar to that present in HD. If true, then some of the gene expression changes observed in HD might also be observed in the neuronal GLT-1 knockout. In situ hybridization using 33P labeled oligonucleotide probes was carried out to assess localization and expression of a panel of genes known to be altered in expression in HD. We found changes in the expression of cannabinoid receptors 1 and 2, preproenkaphalin, and PDE10A in the striatum of mice in which the GLT-1 gene was inactivated in neurons by expression of synapsin-Cre, compared to wild-type littermates. These changes in expression were observed at 12 weeks of age but not at 6 weeks of age. No changes in DARPP-32, PDE1B, NGFIA, or β-actin expression were observed. In addition, we found widespread alteration in expression of the dynamin 1 gene. The changes in expression in the neuronal GLT-1 knockout of genes thought to exemplify HD transcriptional dysregulation suggest an overlap in the synaptopathy caused by neuronal GLT-1 deletion and HD. These data further suggest that specific changes in expression of cannabinoid receptors, preproenkephalin, and PDE10A, considered to be the hallmark of HD transcriptional dysregulation, may be produced by an abnormality of glutamate homeostasis under the regulation of neuronal GLT-1, or a synaptic disturbance caused by that abnormality, independently of mutation in huntingtin.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cannabinoid; Dopamine receptor; Dynamin; EAAT2; PDE10; Preproenkephalin

Mesh:

Substances:

Year:  2018        PMID: 29709465      PMCID: PMC6249114          DOI: 10.1016/j.neuint.2018.04.015

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  59 in total

Review 1.  Transcriptional dysregulation in Huntington's disease.

Authors:  J H Cha
Journal:  Trends Neurosci       Date:  2000-09       Impact factor: 13.837

2.  Dynamin is a minibrain kinase/dual specificity Yak1-related kinase 1A substrate.

Authors:  Mo-Chou Chen-Hwang; Huey-Ru Chen; Marshall Elzinga; Yu-Wen Hwang
Journal:  J Biol Chem       Date:  2002-03-04       Impact factor: 5.157

Review 3.  Emerging biology of PDE10A.

Authors:  Lindsay S Wilson; Nicholas J Brandon
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

4.  Conditional deletion of the glutamate transporter GLT-1 reveals that astrocytic GLT-1 protects against fatal epilepsy while neuronal GLT-1 contributes significantly to glutamate uptake into synaptosomes.

Authors:  Geraldine T Petr; Yan Sun; Natalie M Frederick; Yun Zhou; Sameer C Dhamne; Mustafa Q Hameed; Clive Miranda; Edward A Bedoya; Kathryn D Fischer; Wencke Armsen; Jianlin Wang; Niels C Danbolt; Alexander Rotenberg; Chiye J Aoki; Paul A Rosenberg
Journal:  J Neurosci       Date:  2015-04-01       Impact factor: 6.167

Review 5.  Striatal specificity of gene expression dysregulation in Huntington's disease.

Authors:  Elizabeth A Thomas
Journal:  J Neurosci Res       Date:  2006-11-01       Impact factor: 4.164

6.  Evidence for coexistence of enkephalin and glutamate in axon terminals and cellular sites for functional interactions of their receptors in the rat locus coeruleus.

Authors:  E J Van Bockstaele; A Saunders; K G Commons; X B Liu; J Peoples
Journal:  J Comp Neurol       Date:  2000-01-31       Impact factor: 3.215

7.  Co-compartmentalization of the astroglial glutamate transporter, GLT-1, with glycolytic enzymes and mitochondria.

Authors:  Elizabeth N Genda; Joshua G Jackson; Amanda L Sheldon; Susannah F Locke; Todd M Greco; John C O'Donnell; Lynn A Spruce; Rui Xiao; Wensheng Guo; Mary Putt; Steven Seeholzer; Harry Ischiropoulos; Michael B Robinson
Journal:  J Neurosci       Date:  2011-12-14       Impact factor: 6.167

8.  The cytokine and endocannabinoid systems are co-regulated by NF-κB p65/RelA in cell culture and transgenic mouse models of Huntington's disease and in striatal tissue from Huntington's disease patients.

Authors:  Robert B Laprairie; Jordan R Warford; Sarah Hutchings; George S Robertson; Melanie E M Kelly; Eileen M Denovan-Wright
Journal:  J Neuroimmunol       Date:  2013-12-12       Impact factor: 3.478

9.  An [Na+ + K+]coupled L-glutamate transporter purified from rat brain is located in glial cell processes.

Authors:  N C Danbolt; J Storm-Mathisen; B I Kanner
Journal:  Neuroscience       Date:  1992-11       Impact factor: 3.590

Review 10.  Corticostriatal Dysfunction in Huntington's Disease: The Basics.

Authors:  Kendra D Bunner; George V Rebec
Journal:  Front Hum Neurosci       Date:  2016-06-28       Impact factor: 3.169

View more
  5 in total

1.  Deletion of Neuronal GLT-1 in Mice Reveals Its Role in Synaptic Glutamate Homeostasis and Mitochondrial Function.

Authors:  Laura F McNair; Jens V Andersen; Blanca I Aldana; Michaela C Hohnholt; Jakob D Nissen; Yan Sun; Kathryn D Fischer; Ursula Sonnewald; Nils Nyberg; Sophie C Webster; Kush Kapur; Theresa S Rimmele; Ilaria Barone; Hannah Hawks-Mayer; Jonathan O Lipton; Nathaniel W Hodgson; Takao K Hensch; Chiye J Aoki; Paul A Rosenberg; Helle S Waagepetersen
Journal:  J Neurosci       Date:  2019-03-29       Impact factor: 6.167

Review 2.  Molecular Pathophysiological Mechanisms in Huntington's Disease.

Authors:  Anamaria Jurcau
Journal:  Biomedicines       Date:  2022-06-17

3.  Deletion of the Sodium-Dependent Glutamate Transporter GLT-1 in Maturing Oligodendrocytes Attenuates Myelination of Callosal Axons During a Postnatal Phase of Central Nervous System Development.

Authors:  Elizabeth J Thomason; Edna Suárez-Pozos; Fatemah S Afshari; Paul A Rosenberg; Jeffrey L Dupree; Babette Fuss
Journal:  Front Cell Neurosci       Date:  2022-06-03       Impact factor: 6.147

Review 4.  Glutamate homeostasis and dopamine signaling: Implications for psychostimulant addiction behavior.

Authors:  Kathryn D Fischer; Lori A Knackstedt; Paul A Rosenberg
Journal:  Neurochem Int       Date:  2020-11-05       Impact factor: 3.921

Review 5.  Reconstitution of GABA, Glycine and Glutamate Transporters.

Authors:  Niels Christian Danbolt; Beatriz López-Corcuera; Yun Zhou
Journal:  Neurochem Res       Date:  2021-04-27       Impact factor: 3.996

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.